birtamimab
prothena
['birtamimab']
fantastic presentation from .#birtamimab showed significant survival advantage in patients mayo 2012 stage 4 al amyloid, in post hoc analysis. more to come from ongoing #affirm-al #alamyloid #ash2022 
Hematologist @Mayoclinic Rochester | proud #uwigrad |#Downstate-alum. Lets talk dyspro #MM and oncolytic virotherapy